The content in this web site is not intended to provide medical advice or to provide instructions on the use of our products or drug candidates, and should not be relied upon as the basis of any healthcare decision. The content is not intended to replace informed medical advice from your qualified healthcare provider regarding any questions or concerns you may have about your health or about the potential beneficial uses and possible adverse effects of any healthcare product.
Nothing in this web site constitutes or is intended to constitute an invitation or offer to invest in the securities of Amylin Pharmaceuticals, Inc.
AMYLIN®, BYETTA®, SYMLIN® are registered trademarks of Amylin Pharmaceuticals, Inc. All other trademarks are the property of their respective owners.
Forward-Looking StatementsThe content in this web site may contain forward-looking statements. Any statements about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking. These statements are often, but not always, made through the use of words or phrases such as "anticipate," "estimate," "plan," "project," "continuing," "ongoing," "expect," "will," "could," "may," "management believes," "we believe," "we intend" and similar words or phrases. Accordingly, these statements involve estimates, assumptions and uncertainties which could cause actual results to differ materially from those expressed in them. Any forward-looking statements are qualified in their entirety by reference to the following key factors that could cause actual results to differ materially from the forward-looking statements:
- scientific and technological uncertainties regarding our products or drug candidates;
- risks and uncertainties regarding the adequacy of our clinical trial processes and whether the results of those clinical trials will be adequate to support regulatory filings and/or approvals;
- risks associated with timing of clinical trials for our drug candidates;
- risks associated with timing of regulatory approval of our drug candidates by the U.S. Food and Drug Administration, or FDA, and other regulatory agencies;
- developments or changes in our relationships with current or future collaborative partners;
- our ability to raise additional needed capital or consummate strategic or corporate partner transactions on favorable terms or at all; and
- dependence on third party service providers and manufacturers of our products.
Because the factors referred to above could cause actual results or outcomes to differ materially from those expressed in any forward-looking statements made by us or on our behalf, you should not place undue reliance on any forward-looking statements. You should read these factors and the other cautionary statements we make as being applicable to all related forward-looking statements that we make in this web site. Further, any forward-looking statement speaks only as of the date on which it is made. New factors emerge from time to time, and it is not possible for us to predict which factors will arise. Moreover, additional risks and uncertainties that we are unaware of or that we currently deem immaterial also may become important factors that affect our company. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.
The information contained in this web site was current as of the date such information was posted. The information contained in each press release included in this web site was current as of the date of that press release. We intend to provide updates to information on this web site, as appropriate. In advance of such updates, please send inquiries about the existence of more current, publicly available information on a particular subject to email@example.com.
We will do our best to respond to all inquiries, but cannot guarantee that we will be able to provide a timely answer to any particular inquiry.
Your License to Use this Web Site is Limited
Subject to the terms and conditions of this agreement, Amylin grants you a non-exclusive, non-transferable, limited right to access, use and display this web site and its content. You agree not to interrupt or attempt to interrupt the operation of this web site in any way.
Amylin authorizes you to view and download the content of this web site only for your personal, non-commercial use. This authorization is not a transfer of title in the content or copies of the content and is subject to the following restrictions: 1) you must retain, on all copies of any content downloaded, all copyright and other proprietary notices contained in the content; 2) you may not modify the content in any way or reproduce or publicly display, perform, or distribute or otherwise use them for any public or commercial purpose; and 3) you must not transfer the content to any other person unless you give them notice of, and they agree to accept, the obligations arising under this agreement. You agree to abide by all additional restrictions displayed on the web site as it may be updated from time to time. Except as expressly provided herein, Amylin does not grant any express or implied right to you under any patents, trademarks, copyrights or trade secret information.
THIS WEB SITE AND ITS CONTENT MAY CONTAIN INACCURACIES AND TYPOGRAPHICAL ERRORS. AMYLIN DOES NOT WARRANT THE ACCURACY OR COMPLETENESS OF THIS WEB SITE OR THE CONTENT OR THE RELIABILITY OF ANY STATEMENT OR OTHER INFORMATION DISPLAYED OR DISTRIBUTED THROUGH THE WEB SITE. YOU ACKNOWLEDGE THAT ANY RELIANCE ON ANY SUCH STATEMENT OR INFORMATION SHALL BE AT YOUR SOLE RISK. AMYLIN RESERVES THE RIGHT, IN ITS SOLE DISCRETION, TO CORRECT ANY ERRORS OR OMISSIONS IN ANY PORTION OF THE WEB SITE OR THE CONTENT. AMYLIN MAY MAKE ANY OTHER CHANGES TO THE WEB SITE, THE CONTENT, AND THE PRODUCTS, PROGRAMS, SERVICES (IF ANY) DESCRIBED IN THE WEB SITE AT ANY TIME WITHOUT NOTICE.
THIS WEB SITE, AND THE CONTENT MADE AVAILABLE ON THIS WEB SITE, ARE PROVIDED "AS IS" WITHOUT ANY REPRESENTATION OR WARRANTY, EXPRESS OR IMPLIED, OF ANY KIND, INCLUDING, BUT NOT LIMITED TO, WARRANTIES OF MERCHANTABILITY, NONINFRINGEMENT, OR FITNESS FOR ANY PARTICULAR PURPOSE. SOME JURISDICTIONS DO NOT ALLOW FOR THE EXCLUSION OF IMPLIED WARRANTIES, SO THE ABOVE EXCLUSIONS MAY NOT APPLY TO YOU.
Third Party Sites
As a convenience to you, Amylin may provide, on this web site, links to web sites operated by other entities. If you use these sites, you will leave this web site. If you decide to visit any linked web site, you do so at your own risk and it is your responsibility to take all protective measures to guard against viruses or other destructive elements. Amylin makes no warranty or representation regarding, and does not endorse, any linked web sites or the information appearing thereon or any of the products or services described thereon. Links do not imply that Amylin or this web site sponsors, endorses, is affiliated or associated with, or is legally authorized to use any trademark, trade name, logo or copyright symbol displayed in or accessible through the links, or that any linked web site is authorized to use any trademark, trade name, logo or copyright symbol of Amylin or any of its affiliates or subsidiaries.
Information Provided By You
Limitations of Damages
IN NO EVENT SHALL AMYLIN, ITS AFFILIATES, OR ANY OF ITS SUBSIDIARIES OR CORPORATE PARTNERS BE LIABLE TO ANY ENTITY FOR ANY DIRECT, INDIRECT, SPECIAL, CONSEQUENTIAL OR OTHER DAMAGES (INCLUDING, WITHOUT LIMITATION, ANY LOST PROFITS, BUSINESS INTERRUPTION, LOSS OF INFORMATION OR PROGRAMS OR OTHER DATA ON YOUR INFORMATION HANDLING SYSTEM) THAT ARE RELATED TO THE USE OF, OR THE INABILITY TO USE, THE CONTENT, MATERIALS, AND FUNCTIONS OF THIS WEB SITE OR ANY LINKED WEB SITE, EVEN IF AMYLIN IS EXPRESSLY ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
International Users and Choice of Law